Very long ‐term prognosis in patients with hypertrophic cardiomyopathy: a longitudinal study with a period of 20 years

ConclusionsIn our cohort of patients, HCM-related mortality was relatively favourable. However, approximately half of the patients suffered from HCM-related adverse events during the follow-up period of 20  years. It is important for HCM patients to be carefully followed up over the long-term because HCM is a lifelong disease.

Source: ESC Heart Failure - June 2, 2022 Category: Cardiology Authors: Kenta Sugiura, Toru Kubo, Yuri Ochi, Kazuya Miyagawa, Yuichi Baba, Tatsuya Noguchi, Takayoshi Hirota, Naohito Yamasaki, Yoshinori L. Doi, Hiroaki Kitaoka Tags: Original Article Source Type: research